(Q46758021)

English

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study

scientific article published in March 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: experience from the PRESENT study (English)

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

type 2 diabetes

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

D Khutsoane

1

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

S K Sharma

2

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

M Almustafa

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

H C Jang

4

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

S T Azar

5

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

R Danciulescu

6

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

M Shestakova

7

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

N M A Ayad

8

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

S Guler

9

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

O M Bech

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

PRESENT Study Group

11

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

publication date

1 March 2008

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

Diabetes, Obesity and Metabolism

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

10

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

3

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

212-222

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Utility of casual postprandial glucose levels in type 2 diabetes management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study, 11-year follow-up

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Effect of glycemia on mortality in Pima Indians with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Postprandial glucose regulation: new data and new implications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Premixed insulin treatment for type 2 diabetes: analogue or human?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Premixed insulin analogues for the treatment of diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Starting patients with type 2 diabetes on insulin therapy using once-daily injections of biphasic insulin aspart 70/30, biphasic human insulin 70/30, or NPH insulin in combination with metformin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Reduced postprandial glycaemic excursion with biphasic insulin Aspart 30 injected immediately before a meal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Postprandial versus preprandial dosing of biphasic insulin aspart in elderly type 2 diabetes patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Importance of observational studies in clinical practice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Hypoglycemia in type 2 diabetes: pathophysiology, frequency, and effects of different treatment modalities

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Hypoglycemia in hospitalized adult patients without diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Evaluation of patients admitted with hypoglycaemia to a teaching hospital in Central Anatolia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Biphasic insulin aspart 30: literature review of adverse events associated with treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Progression of retinopathy after change of treatment from oral antihyperglycemic agents to insulin in patients with NIDDM.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1463-1326.2007.00826.X

21 January 2018

Identifiers

10.1111/J.1463-1326.2007.00826.X

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

1 reference

Europe PubMed Central

24 December 2017

http://europepmc.org/abstract/MED/18269636

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46758021&oldid=2129974695"